Key Market Indicators
Sales of digestive system disorder medicine in New Zealand are projected to reach $78.7 million by 2026. This figure is up from $73.6 million in 2021, representing an average annual growth rate of 1.1%. Since 1998, the New Zealand market has grown at an average rate of 3% each year. In 2021, it ranked 24th in the world. Slovakia was ahead with $73.6 million. Japan, South Korea and Canada came in at 2nd, 3rd and 4th respectively.
